The Role of Remifentanil in Obstetric Analgesia: A Review

ŠTOURAČ, Petr, Olga SMÉKALOVÁ, Martina KOSINOVÁ, Hana HARAZIM, Petr JANKŮ and Martin HUSER. The Role of Remifentanil in Obstetric Analgesia: A Review. In Leon V. Berhardt. Advances in Medicine and Biology. 1st ed. New York: Nova Science Publishers, 2016, p. 1-16. ISBN 978-1-63484-186-3.

Basic information

Original name

The Role of Remifentanil in Obstetric Analgesia: A Review

Name in Czech

Úloha remifentanilu v porodnické analgezii: review

Authors

ŠTOURAČ, Petr (203 Czech Republic, guarantor, belonging to the institution), Olga SMÉKALOVÁ (203 Czech Republic, belonging to the institution), Martina KOSINOVÁ (203 Czech Republic, belonging to the institution), Hana HARAZIM (703 Slovakia, belonging to the institution), Petr JANKŮ (203 Czech Republic, belonging to the institution) and Martin HUSER (203 Czech Republic, belonging to the institution)

Edition

1. vyd. New York, Advances in Medicine and Biology, p. 1-16, 16 pp. 2016

Publisher

Nova Science Publishers

---

Other information

Language

English

Type of outcome

Kapitola resp. kapitoly v odborné knize

Field of Study

30000 3. Medical and Health Sciences

Country of publisher

United States of America

Confidentiality degree

není předmětem státního či obchodního tajemství

Publication form

printed version "print"

RIV identification code

RIV/00216224:14110/16:00089368

Organization unit

Faculty of Medicine

ISBN

978-1-63484-186-3

Keywords (in Czech)

remifentanil; porodnická analgezie; pacientem kontrolovaná analgezie; systémová analgezie opioidem

Keywords in English

remifentanil; labour analgesia; patient-controlled anagesia; systemic opioid analgesia

Tags

EL OK

Tags

International impact, Reviewed

---

Abstract

V originále

Standard for labour analgesia due to its efficacy. In cases of contraindication, systemic remifentanil is possible as alternative. The first demonstration of the safety of remifentanil in obstetric analgesia was in 1996 and since then, its safety for mother and newborn has been repeatedly confirmed. The aim of this review is to provide a summary of current information on the efficacy and safety of remifentanil during labour. Methods: Search of the US National Library of Medicine, National Institutes of Health (www.pubmed.gov), SCOPUS database (www.scopus.com) and Web of Science database (www.webofknowledge.com) using the key words “labour” and “remifentanil.” Results: Forty four identified articles were included into review. We described possible modes of application, dosage and side-effects for mother, fetus or newborn in the review. Conclusion: Administration of remifentanil is appropriate, effective, and with respects to the mentioned safety principles also a safe alternative to epidural analgesia in labour. It is highly satisfactory and comparable to epidural analgesia for parturients despite the fact that the analgesic efficacy is significantly lower. Compared to other systemically applied opioids or nitrous oxide, it is more efficient analgesic and due to its unique pharmacokinetics also a safer option. To determine the optimal dosage and mode of administration of remifentanil further studies are needed.

In Czech

Cílem tohoto přehledu je poskytnout shrnutí aktuálních informací o účinnosti a bezpečnosti remifentanilu během porodu. Metody: Hledání US National Library of Medicine, National Institutes of Zdraví (www.pubmed.gov), SCOPUS databáze (www.scopus.com) a Web of Science Databáze (www.web z knowledge.com) s využitím klíčových slov "labour" a "remifentanil."